CytoMed Therapeutics Aktie
Marktkapitalisierung
10,83 Mio. $
10,83 Mio. $
Streubesitz
31,99%
KGV
-5,18
Index-Zuordnung
-
Bilanz/GuV
| Fiskaljahr (Ende: Dezember) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| EBITDA in Mio. | ||||||||
| EBITDA in Mio. | -0 SGD | -1 SGD | -1 SGD | -2 SGD | -3 SGD | -3 SGD | -4 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -1 SGD | -1 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | -0 SGD | -1 SGD | -1 SGD | -1 SGD | -1 SGD | -1 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -1 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | -0 SGD | -1 SGD | -1 SGD | -1 SGD | - | -2 SGD | - |
| Operatives Ergebnis (EBIT) in Mio. | ||||||||
| Operatives Ergebnis (EBIT) in Mio. | -0 SGD | -1 SGD | -1 SGD | -2 SGD | -3 SGD | -3 SGD | -5 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -1 SGD | -1 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | -0 SGD | -1 SGD | -1 SGD | -2 SGD | -1 SGD | -1 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -1 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | -0 SGD | -1 SGD | -1 SGD | -2 SGD | - | -2 SGD | - |
| Finanzergebnis in Mio. | ||||||||
| Finanzergebnis in Mio. | 0 SGD | 1 SGD | 1 SGD | 2 SGD | 2 SGD | 2 SGD | 2 SGD | - |
| Ergebnis vor Steuern (EBT) in Mio. | ||||||||
| Ergebnis vor Steuern (EBT) in Mio. | -1 SGD | -1 SGD | -2 SGD | -2 SGD | -3 SGD | -2 SGD | -4 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -0 SGD | -1 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | -0 SGD | -1 SGD | -1 SGD | -2 SGD | -1 SGD | -1 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | -1 SGD | -0 SGD | -1 SGD | -1 SGD | -1 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | -1 SGD | -1 SGD | -2 SGD | -1 SGD | - | -2 SGD | - |
| Steuern auf Einkommen und Ertrag in Mio. | ||||||||
| Steuern auf Einkommen und Ertrag in Mio. | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | -0 SGD | - |
| Ergebnis nach Steuer in Mio. | ||||||||
| Ergebnis nach Steuer in Mio. | -1 SGD | -1 SGD | -2 SGD | -2 SGD | -3 SGD | -2 SGD | -4 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -0 SGD | -1 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | -0 SGD | -0 SGD | -0 SGD | -1 SGD | -0 SGD | -2 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | -1 SGD | -0 SGD | -1 SGD | -1 SGD | -1 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | -1 SGD | -0 SGD | -2 SGD | -1 SGD | - | -2 SGD | - |
| Nettogewinn/-verlust in Mio. | ||||||||
| Nettogewinn/-verlust in Mio. | - | - | - | - | - | - | - | - |
Aktiva
| Fiskaljahr (Ende: Dezember) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Umlaufvermögen in Mio. | ||||||||
| Umlaufvermögen in Mio. | 0 SGD | 1 SGD | 2 SGD | 2 SGD | 8 SGD | 4 SGD | 4 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | 0 SGD | 4 SGD | 2 SGD | 9 SGD | 6 SGD | 3 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | - | 4 SGD | 2 SGD | 8 SGD | 6 SGD | 3 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | 1 SGD | 2 SGD | 2 SGD | 7 SGD | 5 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | 1 SGD | 2 SGD | 2 SGD | 10 SGD | 6 SGD | 4 SGD | - |
| Anlagevermögen in Mio. | ||||||||
| Anlagevermögen in Mio. | 2 SGD | 2 SGD | 2 SGD | 2 SGD | 2 SGD | 3 SGD | 4 SGD | - |
| Aktiva in Mio. | ||||||||
| Aktiva in Mio. | 2 SGD | 3 SGD | 5 SGD | 4 SGD | 9 SGD | 7 SGD | 8 SGD | - |
Passiva
| Fiskaljahr (Ende: Dezember) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| kurzfristiges Fremdkapital in Mio. | ||||||||
| kurzfristiges Fremdkapital in Mio. | 0 SGD | 2 SGD | 2 SGD | 3 SGD | 1 SGD | 0 SGD | 1 SGD | - |
| langfristiges Fremdkapital in Mio. | ||||||||
| langfristiges Fremdkapital in Mio. | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | - |
| Fremdkapital in Mio. | ||||||||
| Fremdkapital in Mio. | 1 SGD | 3 SGD | 3 SGD | 3 SGD | 1 SGD | 1 SGD | 1 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | -1 SGD | 3 SGD | 3 SGD | 1 SGD | 1 SGD | 1 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | - | 3 SGD | 3 SGD | 1 SGD | 1 SGD | 1 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | 2 SGD | 3 SGD | 3 SGD | 1 SGD | 1 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | 3 SGD | 3 SGD | 5 SGD | 1 SGD | 1 SGD | 1 SGD | - |
| Minderheitenanteil in Mio. | ||||||||
| Minderheitenanteil in Mio. | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | 0 SGD | - |
| Eigenkapital in Mio. | ||||||||
| Eigenkapital in Mio. | 1 SGD | 0 SGD | 2 SGD | 0 SGD | 9 SGD | 7 SGD | 7 SGD | - |
| 1. Quartal | ||||||||
| 1. Quartal | - | 1 SGD | 3 SGD | 1 SGD | 10 SGD | 8 SGD | 5 SGD | - |
| 2. Quartal | ||||||||
| 2. Quartal | - | - | 3 SGD | 1 SGD | 10 SGD | 7 SGD | 6 SGD | - |
| 3. Quartal | ||||||||
| 3. Quartal | - | 0 SGD | 2 SGD | 0 SGD | 8 SGD | 7 SGD | - | - |
| 4. Quartal | ||||||||
| 4. Quartal | - | 0 SGD | 2 SGD | 1 SGD | 11 SGD | 9 SGD | 7 SGD | - |
| Passiva in Mio. | ||||||||
| Passiva in Mio. | 2 SGD | 3 SGD | 5 SGD | 4 SGD | 9 SGD | 7 SGD | 8 SGD | - |
Quelle: Leeway